Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation

NASDAQ:ADPT

Overview | Financials
Company Name Adaptive Biotechnologies Corporation
Symbol ADPT
Currency USD
Price 4.61
Market Cap 679,845,920
Dividend Yield 0%
52-week-range 2.28 - 6.34
Industry Biotechnology
Sector Healthcare
CEO Mr. Chad M. Robins M.B.A, M.B.A.
Website https://www.adaptivebiotech.com

An error occurred while fetching data.

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID

Related Stocks

Innoviva, Inc. logo

Innoviva, Inc.

INVA

19.54 USD

SomaLogic, Inc. logo

SomaLogic, Inc.

SLGC

2.1 USD

NGM Biopharmaceuticals, Inc. logo

NGM Biopharmaceuticals, Inc.

NGM

1.54 USD

Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc.

AGIO

45.54 USD

Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

ALLO

2.88 USD

Instil Bio, Inc. logo

Instil Bio, Inc.

TIL

66.1 USD

RadNet, Inc. logo

RadNet, Inc.

RDNT

67.11 USD

Outset Medical, Inc. logo

Outset Medical, Inc.

OM

0.65 USD

Celularity Inc. logo

Celularity Inc.

CELU

2.56 USD

Financials

Numbers are in millions USD

Numbers are in millions USD